NCT00471549View on ClinicalTrials.gov

Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

June 30, 1991

Study Completion Date

December 31, 1993

Conditions

Type 2 Diabetes

Interventions

DRUG

Statin (simvastatin)

All Listed Sponsors

lead

University of Aarhus

OTHER

NCT00471549 - Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter